Anzeige
Mehr »
Freitag, 04.07.2025 - Börsentäglich über 12.000 News
+210 % Kursgewinn Year to Date: Neuausrichtung nimmt Fahrt auf - jetzt exklusives CEO-Interview ansehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
245 Leser
Artikel bewerten:
(1)

Plasma Protein Therapeutics Market size worth $ 41.20 Billion, Globally, by 2028 at 6.98% CAGR: Verified Market Research

- The rising prevalence of autoimmune disorders, immune deficiency disorders, bleeding disorders as well as increasing adoption of plasma protein therapy in neurology and other therapeutic indications are expected to drive market growth.

JERSEY CITY, N.J., March 24, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Plasma Protein Therapeutics Market" By Product (Human Serum Protein, Plasma-Derived Clotting Factor, Immunoglobulin, and High Immunoglobulin), By Application (Research Laboratories And Institutions, Hospitals, and Stand-Alone Blood Banks), and By Geography. According to Verified Market Research, the Global Plasma Protein Therapeutics Market size was valued at USD 24.10 Billion in 2020 and is projected to reach USD 41.20 Billion by 2028, growing at a CAGR of 6.98% from 2021 to 2028.

Verified Market Research Logo

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=221377

Browse in-depth TOC on "Plasma Protein Therapeutics Market"

202 - Pages
126 - Tables
37 - Figures

Global Plasma Protein Therapeutics Market Overview

The rising prevalence of autoimmune disorders, immune deficiency disorders, bleeding disorders as well as increasing adoption of plasma therapy in neurology and other therapeutic indications are expected to propel the market growth during the forecasted period. There is a rise in the geriatric population, who are more prone to neurological disorders. Additionally, increasing investments in the research and development programs by the pharmaceutical and biotechnology companies' fuels market growth. The ongoing research and development in the plasma protein therapy segment are expected to drive its adoption through several applications. The growing adoption of therapeutic protein drugs in the treatment of a broad range of clinical symptoms is expected to create the potential for this market in future years.

The approval of some new plasma-derived therapies throughout the world will help to increase demand. Over the forecasted period, the aforementioned reasons are likely to boost the growth of the Plasma protein Therapeutics Market. In addition, approval of plasma products across multiple indications, increasing R & D activities, and high demand for advanced therapeutic options are expected to fuel the market growth. Technological advancements, favorable reimbursement policies, and improved standard of living have led to increased life expectancy, contributing to a rise in the geriatric population. Additionally, plasma-derived IG is used to treat a wide range of autoimmune and inflammatory diseases However, the rising use of high-dose therapy, particularly in autoimmune neurologic disorders, is the main cause for IG demand's continued strong growth.

Key Players

The major players in the market are Baxter, CSL Behring, Grifols Therapeutics, Octapharma, Abeona Therapeutics, ADMA Biologics, Amag Pharmaceuticals, Antares Pharma, BioDelivery Sciences, Bio Products Laboratory, Biota Pharmaceuticals, Biotest Pharmaceuticals, and China Biologic Products.

Verified Market Research has segmented the Global Plasma Protein Therapeutics Market On the basis of Product, Application, and Geography.

  • Plasma Protein Therapeutics Market, By Product
    • Human Serum Protein
    • Plasma-Derived Clotting Factor
    • Immunoglobulin
    • High Immunoglobulin
  • Plasma Protein Therapeutics Market, By Application
    • Research Laboratories And Institutions
    • Hospitals
    • Stand-Alone Blood Banks
  • Plasma Protein Therapeutics Market by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Plasma Fractionation Market By Product (Coagulation Factors, Immunoglobulins, Protease Inhibitors, Anticoagulants, Albumins), By Application (Hematology, Hemato-Oncology, Rheumatology, Immunology, Neurology), By Geography, Forecast, 2021-2028

Plasma Therapy Market By End User (Hospitals & Clinics, and Research Institutes), By Application (Cardiac Muscle Injury, Dental, Nerve Injury, Dermatology), By Source (Autologous and Allogenic), By Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin), By Geography, Forecast, 2021-2028

Bone Growth Stimulator Market By Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins, Platelet-Rich Plasma), By Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries), By Geography, Forecast, 2021-2028

Blood Plasma Market By Type (Hyperimmune Globulin, Immunoglobulin, Albumin), By Application (Immunodeficiency Diseases, Hemophilia, Hypogammaglobulinemia), By End-User (Hospitals, Clinics), By Geography, Forecast, 2021-2028

Top 10 Microfluidic Immunoassay Companies restructuring medical testing processes worldwide

Visualize Plasma Protein Therapeutics Market using Verified Market Intelligence:-:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: 1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg

© 2022 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.